Cisplatin Plus Cetuximab Inhibits Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Migration and Proliferation but Does Not Enhance Apoptosis

Cisplatin is among the most widely used anticancer drugs used in the treatment of several malignancies, including oral cancer. However, cisplatin treatment often promotes chemical resistance, subsequently causing treatment failure. Several studies have shown that epidermal growth factor receptors (E...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Hyeong Sim, Kim, Young-Kyun, Yun, Pil-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348335/
https://www.ncbi.nlm.nih.gov/pubmed/34360933
http://dx.doi.org/10.3390/ijms22158167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348335/
https://www.ncbi.nlm.nih.gov/pubmed/34360933
http://dx.doi.org/10.3390/ijms22158167

Ejemplares similares